Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
The Journal of Gene Medicine|March 30, 2000
Keratinocyte growth factor induced epithelial proliferation facilitates retroviral-mediated gene transfer to distal lung epithelia in vivoG Wang, V A Slepushkin, M Bodner, et al.Human Gene Therapy|August 28, 1998
Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liverA Bosch, P B McCray, K S Walters, et al.Cancer Causes & Control : CCC|May 1, 1993
Race and sex differences in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey (United States)J F Dorgan, R G Ziegler, J B Schoenberg, et al.Journal of Exposure Science & Environmental Epidemiology|April 12, 2007
Serum concentrations of chlorinated dibenzo-p-dioxins and dibenzofurans among former Michigan trichlorophenol and pentachlorophenol workersJames J Collins, Kenneth M Bodner, Michael Wilken, et al.Environmental Health Perspectives|November 1, 1992
The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotypeN E Caporaso, P G Shields, M T Landi, et al.Cancer|August 1, 1993
Scientific basis for cancer prevention. Intermediate cancer markersJ L Mulshine, M Jett, F Cuttitta, et al.Journal of Virology|July 10, 1999
The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependentN J DePolo, C E Harkleroad, M Bodner, et al.Oncogene|April 1, 1992
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutationS M Bodner, J D Minna, S M Jensen, et al.Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistanceJ L Mulshine, B E Johnson, A F Gazdar, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Debrisoquine metabolism and lung cancer riskG L Shaw, R T Falk, J Deslauriers, et al.Pageof 15